DOD Multiple Sclerosis Pilot Clinical Trial Award

Funding Opportunity Number: W81XWH-16-MSRP-PCTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 29, 2016Award Ceiling: $0Expected Number of Awards: 2Creation Date: Apr 15, 2016Funding Opportunity Description: The MSRP PCTA mechanism was first offered in FY15. In FY15, 25 PCTA applications were received, and 3 were recommended for funding. The PCTA supports early-phase, proof-of-principle clinical trials to investigate hypothesis-based, innovative interventions that have the potential to result in a profound impact on the management of MS symptoms. While therapeutic approaches proposed for testing through the PCTA must represent novel, hypothesis-based approaches for treating MS symptoms, they may include therapies already in clinical use, or undergoing clinical testing for other diseases, provided that their proposed use for MS would lead to a major advancement for treating one of the disease symptoms. It is anticipated that outcomes from studies funded by this award will provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding